Advertisement

Topics

Evaluating vaccination policies to accelerate measles elimination in China: a meta-population modelling study.

08:00 EDT 11th April 2019 | BioPortfolio

Summary of "Evaluating vaccination policies to accelerate measles elimination in China: a meta-population modelling study."

Measles is among the most highly infectious human diseases. By virtue of increasingly effective childhood vaccination, together with targeted supplemental immunization activities (SIAs), health authorities in the People's Republic of China have reduced measles' reproduction number from about 18 to 2.3. Despite substantial residual susceptibility among young adults, more in some locales than others, sustained routine childhood immunization likely would eliminate measles eventually. To support global eradication efforts, as well as expedite morbidity and mortality reductions in China, we evaluated alternative SIAs via mechanistic mathematical modelling.

Affiliation

Journal Details

This article was published in the following journal.

Name: International journal of epidemiology
ISSN: 1464-3685
Pages:

Links

DeepDyve research library

PubMed Articles [10574 Associated PubMed Articles listed on BioPortfolio]

Characteristics of measles epidemics in China (1951-2004) and implications for elimination: A case study of three key locations.

Measles is a highly infectious, severe viral disease. The disease is targeted for global eradication; however, this result has proven challenging. In China, where countrywide vaccination coverage for ...

Measles Pneumonitis.

Measles represents an acute febrile illness, potentially fatal and highly contagious through the respiratory mode of transmission. Fever combined with one of the following: cough, coryza, conjunctivit...

Characterizing the impact of spatial clustering of susceptibility for measles elimination.

Measles elimination efforts are primarily focused on achieving and maintaining national vaccination coverage goals, based on estimates of the critical vaccination threshold (V): the proportion of the ...

Modeling the Effectiveness of Infection Control Measures for the Elimination of Measles: Focus on Adults Born After 1970.

The German National Action Plan for the implementation of the WHO goal of measles elimination still faces considerable challenges regarding reaching its goal of increasing adult's vaccination rates an...

Successes and challenges for preventing measles, mumps and rubella by vaccination.

The measles, mumps and rubella (MMR) vaccine has an outstanding safety record and is highly efficacious. High coverage with MMR has led to the elimination of endemic measles, rubella, and congenital r...

Clinical Trials [6087 Associated Clinical Trials listed on BioPortfolio]

Ontogeny of Measles Immunity in Infants

This is an immunogenicity study evaluating the development of the immune response of healthy infants following primary vaccination with Attenuvax at 6 or 9 months of age compared with resp...

Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines

Japanese encephalitis (JE) is the leading cause of viral neurological disease and disability in Asia. A live attenuated vaccine (LJEV) manufactured in China has several advantages over oth...

Early Two-Dose Measles Vaccination Trial

The specific aims are to examine in Guinea-Bissau: - whether the standard titre Schwarz (SW) or standard-titre Edmonston-Zagreb (EZ) measles vaccine will be the best vaccine strai...

IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis

Atopic dermatitis (AD) is a chronic inflammatory disease of the skin. AD is very frequent, and involves T lymphocytes cells. Measles vaccination, as well as measles vaccine, induces a temp...

Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine

This trial will evaluate the safety and immunogenicity of: i) measles vaccine (CAM-70) after primary dose at 6 months (MV1) and booster vaccination at 12 months (MV2); ii) a single dose of...

Medical and Biotech [MESH] Definitions

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed)

Meta-analysis of randomized trials in which estimates of comparative treatment effects are visualized and interpreted from a network of interventions that may or may not have been evaluated directly against each other. Common considerations in network meta-analysis include conceptual and statistical heterogeneity and incoherence.

Group activities directed against VACCINATION.

Rate of VACCINATION as defined by GEOGRAPHY and or DEMOGRAPHY.

The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Measles
Measles (morbilli, rubeola) is a highly infectious viral illness that can be very unpleasant and can sometimes lead to serious complications.  The initial symptoms of measles develop around 10 days after initial infection: a high temperature (...


Searches Linking to this Article